UBS Raises Price Target on Dick's Sporting Goods (DKS) Despite 4Q Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Pre-Open Stock Movers 03/08: (SUNE) (XNCR) (URNB) Higher; (ACRX) (EPE) (SHAK) Lower (more...)
March 8, 2016 9:25 AM ESTSunEdison, Inc. (NYSE: SUNE) 24% HIGHER; Vivint Solar (NYSE: VSLR) announced this morning that it had delivered a letter to SunEdison, Inc. (NYSE: SUNE) last night notifying it that, as a result of SunEdison's failure to meet its obligations under the merger agreement pursuant to which the Company was to have been acquired by SunEdison, Vivint Solar has terminated such agreement. Vivint Solar reserves all rights under the merger agreement. In particular,... More
Dick's Sporting Goods (DKS) Misses Q4 EPS by 2c; Issues Light EPS Outlook
March 8, 2016 7:32 AM ESTDick's Sporting Goods (NYSE: DKS) reported Q4 EPS of $1.13, $0.02 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $2.24 billion versus the consensus estimate of $2.28 billion.
Comps fell 2.5 percent.
Sees FY16 EPS of $2.85 - $3.00 and comps flat... More
After-Hours Stock Movers 03/07: (XNCR) (LNCO) (URBN) Higher; (ACRX) (SHAK) (ILMN) Lower (more...)
March 7, 2016 6:03 PM ESTXencor, Inc. (NASDAQ: XNCR) 30.4% HIGHER; announced dosing the first patient in a Phase 2 trial of XmAb®5871 in patients with IgG4-Related Disease (IgG4-RD). The Company also announced dosing the first patient in a Phase 2 trial of XmAb5871 in patients with Systemic Lupus Erythematosus (SLE).
Linn Co, LLC (NASDAQ: LNCO) 14.6% HIGHER; adds to recent gains, including today's 109% surge.
AcelRx Pharma (NASDAQ: ACRX) 12.5% LOWER; reported Q4 EPS of ($0.24), $0.14... More
